Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

ENTAENTA
Showing 8 of 31 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in ENANTA PHARMACEUTICALS INC

BNP PARIBAS FINANCIAL MARKETS holds 4,278 shares of ENTA (ENANTA PHARMACEUTICALS INC), worth $62,373 as of 2026-Q2. The position was decreased (-74.5% shares).

Current Value

$62,373

Current Shares

4,278

Total Value Change

-$304,464

Total Shares Change

-31,131

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
4,278
-74.5%
$62,3730.0%$14.58
0
2026-Q1
Decreased
16,809
-83.2%
$212,2980.0%$14.72
0
2025-Q4
Increased
99,884
+404.0%
$1.6M0.0%$15.90
41
2025-Q3
Decreased
19,820
-49.5%
$237,2450.0%$15.16
0
2025-Q2
Decreased
39,256
-17.5%
$296,7750.0%$7.50
0
2025-Q1
Decreased
47,607
-33.0%
$262,7910.0%$5.71
0
2024-Q4
Increased
71,104
+100.8%
$408,8480.0%$5.85
38
2024-Q3
Increased
35,409
+1.9%
$366,8370.0%$10.05
24

Other major holders of ENTA: FARALLON CAPITAL MANAGEMENT, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used